Literature DB >> 202968

Inhibition of angiotensin-converting enzyme by SQ 14,225 in anesthetized dogs: hemodynamic and renal vascular effects.

V S Murthy, T L Waldron, M E Goldberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 202968     DOI: 10.3181/00379727-157-40004

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  5 in total

Review 1.  Preclinical studies on angiotensin converting enzyme inhibitors.

Authors:  I L Natoff
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

2.  Effects of the angiotensin converting enzyme inhibitor, captopril, in essential hypertension.

Authors:  B C Campbell; A N Shepherd; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

3.  Long-term effects of captopril on renal function in hypertensive patients.

Authors:  Z Glück; C Beretta-Piccoli; F C Reubi
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 4.  Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

5.  Role of various vasodepressor systems in the acute hypotensive effect of captopril in man.

Authors:  P Lijnen; R Fagard; J Staessen; L J Verschueren; A Amery
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.